EPHB1 and acute myeloid leukemia: Another study of bone marrow mononuclear cells from pediatric AML patients reported decreased EPHB1 phosphorylation and mRNA expression compared to the healthy controls, with the majority of AML specimens presenting hypermethylation of the EPHB1 promoter.